Swiss pharma hub Basel frets over population cap threat - Reuters

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxOR2R1XzUtSG9VVTU3TFIyTnZMUlV0eUZKMHZIZ080RnA2d2VFVkRfNEZBcGtqbVFuN2FycjBBN083TnRtVjB3TzhieDFzV2Vkbnp4a0c1RW9zSlpZb2dSTGRDSm51aEpNbWFFWE13cU1tT2FSTXJFOWdWQXRXd2lQczEyX2R5RnhVaFp3YWcyTVpKWW9QbWRmenUzZ0ljYVoyQWc?oc=5" target="_blank">Swiss pharma hub Basel frets over population cap threat</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

Basel's pharmaceutical industry, including giants Roche and Novartis, expresses concern over a proposed population cap in Switzerland, fearing it could hinder access to skilled labor and impact economic growth.

Executives, including Roche's chairman, express concerns over a proposed population cap in Switzerland, emphasizing the need for international talent to sustain economic growth.

Swiss businesses, including pharmaceutical companies, express concerns over a proposed population cap, fearing it could limit access to skilled labor and strain relations with the European Union.